YahooOctober 16, 2026 at 8:41 AM NY11 Days Ago
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
DHR's Q3 results are due Oct. 21, with growth in Biotechnology, Diagnostics and Life Sciences expected to boost revenues, while rising costs and currency headwinds weigh on earnings.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
